BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 34809637)

  • 1. Risk of bias in observational studies using routinely collected data of comparative effectiveness research: a meta-research study.
    Nguyen VT; Engleton M; Davison M; Ravaud P; Porcher R; Boutron I
    BMC Med; 2021 Nov; 19(1):279. PubMed ID: 34809637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specifying a target trial prevents immortal time bias and other self-inflicted injuries in observational analyses.
    Hernán MA; Sauer BC; Hernández-Díaz S; Platt R; Shrier I
    J Clin Epidemiol; 2016 Nov; 79():70-75. PubMed ID: 27237061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methodological biases in observational hospital studies of COVID-19 treatment effectiveness: pitfalls and potential.
    Martinuka O; Hazard D; Marateb HR; Mansourian M; Mañanas MÁ; Romero S; Rubio-Rivas M; Wolkewitz M
    Front Med (Lausanne); 2024; 11():1362192. PubMed ID: 38576716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementation of the trial emulation approach in medical research: a scoping review.
    Scola G; Chis Ster A; Bean D; Pareek N; Emsley R; Landau S
    BMC Med Res Methodol; 2023 Aug; 23(1):186. PubMed ID: 37587484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overview of the epidemiology methods and applications: strengths and limitations of observational study designs.
    Colditz GA
    Crit Rev Food Sci Nutr; 2010; 50 Suppl 1(s1):10-2. PubMed ID: 21132580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time-dependent biases in observational studies of comparative effectiveness research in rheumatology. A methodological review.
    Iudici M; Porcher R; Riveros C; Ravaud P
    Ann Rheum Dis; 2019 Apr; 78(4):562-569. PubMed ID: 30755417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Target trial emulation with multi-state model analysis to assess treatment effectiveness using clinical COVID-19 data.
    Martinuka O; Hazard D; Marateb HR; Maringe C; Mansourian M; Rubio-Rivas M; Wolkewitz M
    BMC Med Res Methodol; 2023 Sep; 23(1):197. PubMed ID: 37660025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Consideration of confounding was suboptimal in the reporting of observational studies in psychiatry: a meta-epidemiological study.
    Munkholm K; Faurholt-Jepsen M; Ioannidis JPA; Hemkens LG
    J Clin Epidemiol; 2020 Mar; 119():75-84. PubMed ID: 31809848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Data source profile reporting by studies that use routinely collected health data to explore the effects of drug treatment.
    Wang W; Liu M; He Q; Wang M; Xu J; Li L; Li G; He L; Zou K; Sun X
    BMC Med Res Methodol; 2023 Apr; 23(1):95. PubMed ID: 37081410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methodological evaluation of bias in observational coronavirus disease 2019 studies on drug effectiveness.
    Martinuka O; von Cube M; Wolkewitz M
    Clin Microbiol Infect; 2021 Jul; 27(7):949-957. PubMed ID: 33813117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analysis: Problems with Russian Publications.
    Verbitskaya EV
    Int J Risk Saf Med; 2015; 27 Suppl 1():S89-90. PubMed ID: 26639728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation and impact of algorithms for identifying variables in observational studies of routinely collected data.
    Wang W; Liu M; He Q; Wang M; Xu J; Li L; Li G; He L; Zou K; Sun X
    J Clin Epidemiol; 2024 Feb; 166():111232. PubMed ID: 38043830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New-user and prevalent-user designs and the definition of study time origin in pharmacoepidemiology: A review of reporting practices.
    Luijken K; Spekreijse JJ; van Smeden M; Gardarsdottir H; Groenwold RHH
    Pharmacoepidemiol Drug Saf; 2021 Jul; 30(7):960-974. PubMed ID: 33899305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reflection on modern methods: trial emulation in the presence of immortal-time bias. Assessing the benefit of major surgery for elderly lung cancer patients using observational data.
    Maringe C; Benitez Majano S; Exarchakou A; Smith M; Rachet B; Belot A; Leyrat C
    Int J Epidemiol; 2020 Oct; 49(5):1719-1729. PubMed ID: 32386426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Confounding and bias in observational studies in inflammatory bowel disease: a meta-epidemiological study.
    Piovani D; Pansieri C; Peyrin-Biroulet L; Danese S; Bonovas S
    Aliment Pharmacol Ther; 2021 Mar; 53(6):712-721. PubMed ID: 33296517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Designing observational studies by target trial emulation].
    van Gelder MMHJ; Rodwell L; Roes KCB
    Ned Tijdschr Geneeskd; 2023 Nov; 167():. PubMed ID: 37994775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential Pitfalls of Reporting and Bias in Observational Studies With Propensity Score Analysis Assessing a Surgical Procedure: A Methodological Systematic Review.
    Lonjon G; Porcher R; Ergina P; Fouet M; Boutron I
    Ann Surg; 2017 May; 265(5):901-909. PubMed ID: 27232253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Target Trial Emulation Using Hospital-Based Observational Data: Demonstration and Application in COVID-19.
    Martinuka O; Cube MV; Hazard D; Marateb HR; Mansourian M; Sami R; Hajian MR; Ebrahimi S; Wolkewitz M
    Life (Basel); 2023 Mar; 13(3):. PubMed ID: 36983933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Completeness of reporting of systematic reviews in the animal health literature: A meta-research study.
    Sargeant JM; Reynolds K; Winder CB; O'Connor AM
    Prev Vet Med; 2021 Oct; 195():105472. PubMed ID: 34438246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.